241 related articles for article (PubMed ID: 19469259)
1. [Microbiol landscape and production of beta-lactamases with extended spectrum activity in patients with urinary tract infection].
Zhevlakova IuA; Zakharova GV; Khokhlova OI; Ust'iantseva IM
Klin Med (Mosk); 2009; 87(3):56-9. PubMed ID: 19469259
[TBL] [Abstract][Full Text] [Related]
2. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
You JH; Kei HW; Lau WC; Wong KY; Marasinghe T; Lee N; Ip M
J Hosp Infect; 2008 Feb; 68(2):181-3. PubMed ID: 18194826
[No Abstract] [Full Text] [Related]
3. Risks of extended-spectrum beta-lactamases.
BMJ Group
Drug Ther Bull; 2008 Mar; 46(3):21-4. PubMed ID: 18337463
[TBL] [Abstract][Full Text] [Related]
4. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
[TBL] [Abstract][Full Text] [Related]
5. The new beta-lactamases.
Jacoby GA; Munoz-Price LS
N Engl J Med; 2005 Jan; 352(4):380-91. PubMed ID: 15673804
[No Abstract] [Full Text] [Related]
6. [Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
Barcelona L; Marín M; Stamboulian D
Medicina (B Aires); 2008; 68(1):65-74. PubMed ID: 18416324
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs).
Giamarellou H
Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():1-16. PubMed ID: 15953019
[TBL] [Abstract][Full Text] [Related]
8. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
Ko WC; Hsueh PR
J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
[TBL] [Abstract][Full Text] [Related]
9. beta-Lactam resistance and beta-lactamases in bacteria of animal origin.
Li XZ; Mehrotra M; Ghimire S; Adewoye L
Vet Microbiol; 2007 Apr; 121(3-4):197-214. PubMed ID: 17306475
[TBL] [Abstract][Full Text] [Related]
10. Parenteral carbapenems.
Shah PM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
[TBL] [Abstract][Full Text] [Related]
11. IRT and CMT beta-lactamases and inhibitor resistance.
Cantón R; Morosini MI; de la Maza OM; de la Pedrosa EG
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():53-62. PubMed ID: 18154528
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report.
Berg ML; Crank CW; Philbrick AH; Hayden MK
Ann Pharmacother; 2008 Feb; 42(2):207-12. PubMed ID: 18230703
[TBL] [Abstract][Full Text] [Related]
13. Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections.
Teng CP; Chen HH; Chan J; Lye DC
Int J Antimicrob Agents; 2007 Oct; 30(4):356-9. PubMed ID: 17631986
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli.
Chatterjee SS; Karmacharya R; Madhup SK; Gautam V; Das A; Ray P
Indian J Med Microbiol; 2010; 28(3):267-8. PubMed ID: 20644325
[No Abstract] [Full Text] [Related]
15. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
Suárez CJ; Lolans K; Villegas MV; Quinn JP
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):915-22. PubMed ID: 16307504
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of sensitivity to antibiotics of microorganisms isolated from children with urinary tract infections].
Cisowska A; Lewczyk E; Korzekwa K; Wojnicz D; Jankowski S; Doroszkiewicz W
Pol Merkur Lekarski; 2003 Apr; 14(82):322-6. PubMed ID: 12868193
[TBL] [Abstract][Full Text] [Related]
17. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of extended-spectrum beta-lactamases in South America.
Villegas MV; Kattan JN; Quinteros MG; Casellas JM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():154-8. PubMed ID: 18154539
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of bacterial beta-lactamase production in the treatment of urinary tract infections with oral beta-lactam-antibiotics].
Naber K; Ahrens T; Zimmermann W; Puppel H; Schultheis H; Maly V
Urologe A; 1982 Jul; 21(4):225-8. PubMed ID: 6982557
[TBL] [Abstract][Full Text] [Related]
20. [Resistance to fluoroquinolone among Klebsiella spp strains producing extended-spectrum betalactamases isolated from urine].
Tlamçani Z; Ellaia K; Benomar A; Kabbaj H; Alaoui A; Seffar M
Ann Biol Clin (Paris); 2009; 67(5):553-6. PubMed ID: 19789127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
